NANAH SESAY: Open Payments
NPI 1306171145 · WOODBRIDGE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,939 in 91 payments from 11 companies in 2025. Trend: 2023 $616 · 2024 $1,158 · 2025 $1,939
Food & beverage: $1,828Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $315 |
| Vanda Pharmaceuticals Inc. | 10 | $273 |
| Neurocrine BioSciences, Inc. | 12 | $244 |
| Alkermes, Inc. | 10 | $222 |
| Teva Pharmaceuticals USA, Inc. | 5 | $177 |
| E.R. Squibb & Sons, L.L.C. | 9 | $156 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $151 |
| Otsuka America Pharmaceutical, Inc. | 6 | $144 |
| Axsome Therapeutics, Inc. | 4 | $96 |
| Lundbeck LLC | 5 | $91 |
Products named: VRAYLAR, INGREZZA, FANAPT, ARISTADA, COBENFY, CAPLYTA, ABILIFY ASIMTUFII, Auvelity.
Industry payments across VA — which companies pay providers there.
